- Home
- CTRM vs BNGO Comparison
CTRM vs BNGO Comparison
Compare CTRM & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- BNGO
- Stock Information
- Founded
- CTRM 2016
- BNGO 2003
- Country
- CTRM Cyprus
- BNGO United States
- Employees
- CTRM N/A
- BNGO N/A
- Industry
- CTRM Marine Transportation
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- CTRM Consumer Discretionary
- BNGO Industrials
- Exchange
- CTRM Nasdaq
- BNGO Nasdaq
- Market Cap
- CTRM 20.7M
- BNGO 24.3M
- IPO Year
- CTRM N/A
- BNGO 2018
- Fundamental
- Price
- CTRM $2.34
- BNGO $3.74
- Analyst Decision
- CTRM
- BNGO Buy
- Analyst Count
- CTRM 0
- BNGO 4
- Target Price
- CTRM N/A
- BNGO $7.00
- AVG Volume (30 Days)
- CTRM 42.5K
- BNGO 74.6K
- Earning Date
- CTRM 05-23-2025
- BNGO 05-14-2025
- Dividend Yield
- CTRM N/A
- BNGO N/A
- EPS Growth
- CTRM N/A
- BNGO N/A
- EPS
- CTRM 2.39
- BNGO N/A
- Revenue
- CTRM $76,443,340.00
- BNGO $30,776,000.00
- Revenue This Year
- CTRM N/A
- BNGO $0.53
- Revenue Next Year
- CTRM N/A
- BNGO $10.22
- P/E Ratio
- CTRM $1.02
- BNGO N/A
- Revenue Growth
- CTRM N/A
- BNGO N/A
- 52 Week Low
- CTRM $1.98
- BNGO $2.68
- 52 Week High
- CTRM $5.49
- BNGO $72.60
- Technical
- Relative Strength Index (RSI)
- CTRM 55.58
- BNGO 44.89
- Support Level
- CTRM $2.07
- BNGO $3.61
- Resistance Level
- CTRM $2.58
- BNGO $4.10
- Average True Range (ATR)
- CTRM 0.13
- BNGO 0.25
- MACD
- CTRM 0.04
- BNGO -0.03
- Stochastic Oscillator
- CTRM 52.78
- BNGO 14.29
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.